Zhaoqing Cong

Title(s)Postdoctoral Scholar, Biochemistry and Molecular Medicine
SchoolSchool of Medicine
ORCID ORCID Icon0000-0003-2737-7636 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Peking Union Medical College, BeijingPhD07/2020Pharmaceutics
    Xi'an Jiaotong University, Xi'anBS07/2015Pharmacy, Economics
    University of California, Davis, Sacramento11/2018Biochemistry

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Corrigendum to "Pulmonary delivery of size-transformable nanoparticles improves tumor accumulation and penetration for chemo-sonodynamic combination therapy" [Journal of Controlled Release 350 (2022) 132-145]. J Control Release. 2025 Jun 10; 382:113747. Ma S, Cong Z, Wei J, Chen W, Ge D, Yang F, Liao Y. PMID: 40267523.
      View in: PubMed   Mentions:    Fields:    
    2. Multifunctional and Scalable Nanoparticles for Bimodal Image-Guided Phototherapy in Bladder Cancer Treatment. Nanomicro Lett. 2025 Apr 18; 17(1):222. Tang M, Mahri S, Shiau YP, Mukarrama T, Villa R, Zong Q, Racacho KJ, Li Y, Lee Y, Huang Y, Cong Z, Kim J, Li Y, Lin TY. PMID: 40249569; PMCID: PMC12008111.
      View in: PubMed   Mentions:
    3. Magnetic-Powered Spora Lygodii Microrobots Loaded with Doxorubicin for Active and Targeted Therapy of Bladder Cancer. Drug Des Devel Ther. 2024; 18:5841-5851. Yang Q, Yuan W, Zhao T, Jiao Y, Tang M, Cong Z, Wu S. PMID: 39679132; PMCID: PMC11638078.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    4. Engineered Microrobots for Targeted Delivery of Bacterial Outer Membrane Vesicles (OMV) in Thrombus Therapy. Small. 2024 10; 20(40):e2400847. Cong Z, Li Y, Xie L, Chen Q, Tang M, Thongpon P, Jiao Y, Wu S. PMID: 38801399.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    5. Magnetically Powered Immunogenic Macrophage Microrobots for Targeted Multimodal Cancer Therapy. Small. 2023 10; 19(42):e2301489. Li Y, Cong Z, Xie L, Tang S, Ren C, Peng X, Tang D, Wan F, Han H, Zhang X, Gao W, Wu S. PMID: 37300342.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    6. Bioengineered bacterial outer membrane vesicles encapsulated Polybia-mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy. Front Immunol. 2023; 14:1129771. Ren C, Li Y, Cong Z, Li Z, Xie L, Wu S. PMID: 36999028; PMCID: PMC10043419.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    7. Ovarian Granulosa Cell Tumor Initially Presenting as a Giant Liver Mass Radiologically Mimicking Primary Cystic Cholangiocarcinoma. In Vivo. 2023 Mar-Apr; 37(2):734-737. Qian X, Cong Z, Lai J. PMID: 36881092; PMCID: PMC10026683.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Pulmonary delivery of size-transformable nanoparticles improves tumor accumulation and penetration for chemo-sonodynamic combination therapy. J Control Release. 2022 10; 350:132-145. Ma S, Cong Z, Wei J, Chen W, Ge D, Yang F, Liao Y. PMID: 35940360.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    9. Pollen Typhae-Based Magnetic-Powered Microrobots toward Acute Gastric Bleeding Treatment. ACS Appl Bio Mater. 2022 Aug 15. Yang Q, Tang S, Lu D, Li Y, Wan F, Li J, Chen Q, Cong Z, Zhang X, Wu S. PMID: 35969274.
      View in: PubMed   Mentions: 2     Fields:    
    10. Magnetic-Powered Janus Cell Robots Loaded with Oncolytic Adenovirus for Active and Targeted Virotherapy of Bladder Cancer. Adv Mater. 2022 Jul; 34(26):e2201042. Cong Z, Tang S, Xie L, Yang M, Li Y, Lu D, Li J, Yang Q, Chen Q, Zhang Z, Zhang X, Wu S. PMID: 35452560.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    11. Multifunctional Metal-Organic Framework Exoskeletons Protect Biohybrid Sperm Microrobots for Active Drug Delivery from the Surrounding Threats. ACS Appl Mater Interfaces. 2021 Dec 15; 13(49):58382-58392. Chen Q, Tang S, Li Y, Cong Z, Lu D, Yang Q, Zhang X, Wu S. PMID: 34860489.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. Velvet antler polypeptide-loaded polyvinyl alcohol-sodium alginate hydrogels promote the differentiation of neural progenitor cells in 3D towards oligodendrocytes in vitro. Eur J Pharm Sci. 2021 Dec 01; 167:106003. Ma S, Cong Z, Chen H, Wen H, Cao L, Liu C, Yang F, Liao Y. PMID: 34517106.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    13. Magnetic-Propelled Janus Yeast Cell Robots Functionalized with Metal-Organic Frameworks for Mycotoxin Decontamination. Micromachines (Basel). 2021 Jul 05; 12(7). Lu D, Tang S, Li Y, Cong Z, Zhang X, Wu S. PMID: 34357207; PMCID: PMC8307641.
      View in: PubMed   Mentions: 6  
    14. Enhancing in vivo oral bioavailability of cajaninstilbene acid using UDP-glucuronosyl transferase inhibitory excipient containing self-microemulsion. Colloids Surf B Biointerfaces. 2020 Sep; 193:111069. Yang FF, Ji CY, Cong ZQ, Ma SQ, Liu CY, Pan RL, Chang Q, Ji YB, Liao YH. PMID: 32371286.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    15. Size-Transformable Hyaluronan Stacked Self-Assembling Peptide Nanoparticles for Improved Transcellular Tumor Penetration and Photo-Chemo Combination Therapy. ACS Nano. 2020 02 25; 14(2):1958-1970. Cong Z, Zhang L, Ma SQ, Lam KS, Yang FF, Liao YH. PMID: 32023048.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    16. Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo. Nat Nanotechnol. 2020 02; 15(2):145-153. Zhang L, Jing D, Jiang N, Rojalin T, Baehr CM, Zhang D, Xiao W, Wu Y, Cong Z, Li JJ, Li Y, Wang L, Lam KS. PMID: 31988501; PMCID: PMC7147967.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    17. Fluticasone propionate nanosuspensions for sustained nebulization delivery: An in vitro and in vivo evaluation. Int J Pharm. 2019 Dec 15; 572:118839. Fu TT, Cong ZQ, Zhao Y, Chen WY, Liu CY, Zheng Y, Yang FF, Liao YH. PMID: 31715359.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    18. Alginate Hydrogel Modified with a Ligand Interacting with α3β1 Integrin Receptor Promotes the Differentiation of 3D Neural Spheroids toward Oligodendrocytes in Vitro. ACS Appl Mater Interfaces. 2019 Feb 13; 11(6):5821-5833. Wen H, Xiao W, Biswas S, Cong ZQ, Liu XM, Lam KS, Liao YH, Deng W. PMID: 30645095.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    19. Multispectral optoacoustic tomography (MSOT) for imaging the particle size-dependent intratumoral distribution of polymeric micelles. Int J Nanomedicine. 2018; 13:8549-8560. Cong Z, Yang F, Cao L, Wen H, Fu T, Ma S, Liu C, Quan L, Liao Y. PMID: 30587977; PMCID: PMC6296692.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    20. Improving oral bioavailability of resveratrol by a UDP-glucuronosyltransferase inhibitory excipient-based self-microemulsion. Eur J Pharm Sci. 2018 Mar 01; 114:303-309. Yang FF, Zhou J, Hu X, Cong ZQ, Liu CY, Pan RL, Chang Q, Liu XM, Liao YH. PMID: 29292019.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    21. Effects of Ganoderma, Rhodiola and grape seed extracts on the glucuronidation and oral bioavailability of resveratrol in rats. Nat Prod Res. 2019 Mar; 33(5):767-771. Cong Z, Zhou M, Yang F, Liu C, Pan R, Chang Q, Liu X, Liao Y. PMID: 29172735.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    Zhaoqing's Networks
    Concepts (112)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California